H-EVDPIGHLY-OH

Ref. 3D-PP46939

Product Information

• Name: H-EVDPIGHLY-OH
• Synonyms: NH2-Glu-Val-Asp-Pro-Ile-Gly-His-Leu-Tyr-OH

Description

Peptide H-EVDPIGHLY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EVDPIGHLY-OH include the following: Long-peptide cross-presentation by human dendritic cells occurs in vacuoles by peptide exchange on nascent MHC class I molecules W Ma, Y Zhang , N Vigneron, V Stroobant - The Journal of , 2016 - journals.aai.orghttps://journals.aai.org/jimmunol/article/196/4/1711/43276 A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful W Ma, N Vigneron, J Chapiro - journal of cancer, 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.25911 Induction of human leukocyte antigen (HLA)-A2-restricted and MAGE-3-gene-derived peptide-specific cytolytic T lymphocytes using cultured dendritic cells from an S Kanaoka, S Yamasaki, T Okino - Journal of surgical , 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1096-9098(199905)71:1%3C16::AID-JSO4%3E3.0.CO;2-A Electrophoresis-related protein modification: Alkylation of carboxy residues revealed by mass spectrometry S Haebel, T Albrecht, K Sparbier, P Walden - , 1998 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/elps.1150190513 Chemical derivatization strategy for extending the identification of MHC class I immunopeptides R Chen , F Fauteux , S Foote, J Stupak - Analytical , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.8b02420 Tumor-specific shared antigenic peptides recognized by human T cells P Van Der Bruggen , Y Zhang , P Chaux - Immunological , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1600-065X.2002.18806.x Production of an antigenic peptide by insulin-degrading enzyme N Parmentier, V Stroobant, D Colau - Nature , 2010 - nature.comhttps://www.nature.com/articles/ni.1862 Facile method for screening clinical T cell receptors for off-target peptide-HLA reactivity MH Gee , X Yang , KC Garcia - BioRxiv, 2018 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/472480.abstract Analysis of the degradation mechanisms of MHC class I-presented tumor antigenic peptides by high performance liquid chromatography/electrospray ionization mass M Ayyoub, B Monsarrat, H Mazarguil - in mass spectrometry, 1998 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0231(19980515)12:9%3C557::AID-RCM199%3E3.0.CO;2-D Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies KA Chianese-Bullock, ST Lewis, NE Sherman - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09000553 A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma JS Weber, FL Hua, L Spears, V Marty - Journal of , 1999 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/abstract/1999/09000/a_phase_i_trial_of_an_hla_a1_restricted_mage_3.7.aspx Peptide vaccines for cancer J Weber - Cancer investigation, 2002 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1081/CNV-120001149 HLA Photoaffinity Labeling Reveals Overlapping Binding of Homologous Melanoma-associated Gene Peptides by HLA-A1, HLA-A29, and HLA-B44 (∗) IF Luescher, P Romero, D Kuznetsov, D Rimoldi - Journal of Biological , 1996 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)95440-2/abstract Identification of five new HLA-B* 3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating H Benlalam, B Linard, Y Guilloux - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/171/11/6283/36031 A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes ES Schultz, Y Zhang , R Knowles, J Tine - Tissue , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-0039.2001.057002103.x Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. E Celis, V Tsai, C Crimi, R DeMars - Proceedings of the , 1994 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.91.6.2105 Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides DH Hsu, P Paz, G Villaflor, A Rivas - Journal of , 2003 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2003/09000/exosomes_as_a_tumor_vaccine__enhancing_potency.7.aspx Identification of a titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells BJ Cameron, AB Gerry, J Dukes, JV Harper - Science translational , 2013 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.3006034 CrossDome: an interactive R package to predict cross-reactivity risk using immunopeptidomics databases AF Fonseca, DA Antunes - Frontiers in Immunology, 2023 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1142573/full Stability and CTL-activity of P40/ELA melanoma vaccine candidate A Beck , L Goetsch, T Champion, MC Bussat, JP Aubry - Biologicals, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1045105601903069 Peptides as tools and drugs for immunotherapies A Beck , C Klinguer-Hamour, MC Bussat - Journal of Peptide , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.852

• Brand: Biosynth